Digitalis Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Omni Pet
22 Jun 2026
Omni Pet secures £11m in funding led by IW Capital for veterinary-grade protein nutrition for dogs
Omni Pet is a science-led pet health company that develops calorie-controlled, novel protein foods, treats and supplements for dogs, replacing common allergens such as beef, chicken and dairy with yeast, algae and pulse-based alternatives. Founded by a practising veterinarian, the brand targets dogs with obesity, food allergies and gut sensitivities, and provides round-the-clock vet access to pet owners.
T-Therapeutics
13 Nov 2025
T-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease
T-Therapeutics develops next-generation T cell receptor therapies designed to target cancer and autoimmune disease, advancing bispecific molecules that selectively remove disease-driving immune cells while preserving healthy function.
Digitalis Ventures
More venture news
- 6 Jul 2026
TaiSanTaiSan raises £4.7m in funding led by Eos Advisory and Mercia Ventures for solid-state sodium-ion batteries
EquityDeep Tech - 6 Jul 2026
Revolver TherapeuticsRevolver Therapeutics raises £600k in funding led by QantX to develop peptides that shut down cancer-driving proteins
EquityLife Sciences - 6 Jul 2026
GoniniGonini secures £3.3m in funding from IW Capital to scale global e-commerce fulfilment platform
EquitySupply Chain
